Kestra Medical Technologies (Nasdaq: KMTS) announced it entered a five-year term loan facility with funds managed by Pharmakon Advisors, LP. The release does not disclose loan size, pricing, or any change to guidance, so near-term read-through is limited.
Kestra Medical Technologies (Nasdaq: KMTS) announced it entered a five-year term loan facility with funds managed by Pharmakon Advisors, LP. The release does not disclose loan size, pricing, or any change to guidance, so near-term read-through is limited.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
